Clinimix E 261 mg (Potassium Phosphate Dibasic SOLUTION) 261 MG

Clinimix E 261 mg is an intravenous solution containing potassium phosphate dibasic, designed to support nutritional needs. This product is manufactured by Baxter Corporation in Canada and is commonly used in clinical settings for nutrient supplementation.

Strength

261 MG

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clinimix E 261 mg is primarily used to provide essential nutrients, including potassium and phosphorus, to patients who cannot consume them orally. This solution is often administered intravenously to support overall health and well-being in individuals with specific nutritional deficiencies or those undergoing certain medical treatments. It is important to consult healthcare professionals to determine the appropriate use of this product.

Side Effects

The effects of Clinimix E 261 mg are generally related to the replenishment of potassium and phosphorus levels in the body. Patients may experience improved energy levels and overall well-being as the nutrients are absorbed. However, individual responses can vary, and it is essential to monitor for any adverse reactions.

Precautions & Warnings

Clinimix E 261 mg should be handled with care, ensuring proper storage and administration guidelines are followed. It is crucial to use this solution under the supervision of a healthcare professional to avoid potential complications. Patients with known allergies to any of the components should avoid using this product.

Avoid Interactions

Clinimix E 261 mg may interact with certain medications, particularly those affecting electrolyte balance. It is important to inform healthcare providers about all current medications to avoid potential interactions. Additionally, alcohol and other substances may influence the effectiveness of this solution, so it is advisable to consult a healthcare professional for personalized advice.

Frequently Asked Questions

Clinimix E 261 mg is used to provide essential nutrients, including potassium and phosphorus, to patients who cannot consume them orally.

Clinimix E 261 mg is administered intravenously under the supervision of a healthcare professional.

Common effects include improved energy levels and overall well-being as the nutrients are absorbed.

Yes, it is important to follow proper storage and administration guidelines and to use this solution under the supervision of a healthcare professional.

Yes, it may interact with medications affecting electrolyte balance, so it is important to inform healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.